Accelerating Therapeutic DiscoveryTM

News From The Alpha-1 Project

Entries for September 2015

17
Inhibrx’s AAT-Fc therapeutic should benefit patients with enhanced efficacy and less frequent dosing; Alpha-1 Project collaborates with industry to accelerate drug developmentLA JOLLA, CA and MIAMI, FL, September 16, 2015—Inhibrx and The ...

[Read More...]